ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,352.68
-0.76%
Dow Jones
39,872.99
0.00%
Gold vs US Dollar
2,412.345
-0.37%
Brent Oil
81.905
-0.65%
Bitcoin
69,571.97
-0.80%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Defence Therapeutics Inc (QB) (DTCFF)

  7. Defence Therapeutics Inc (QB) (DTCFF) News

Defence Therapeutics (QB) (DTCFF)

Defence Therapeutics Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:DTCFF
DateTimeSourceHeadlineSymbolCompany
16/02/202215:00InvestorsHub NewsWireDEFENCE RETAINS CATO SMS TO ADVISE ON ITS  PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCERUSOTC:DTCFFDefence Therapeutics Inc (QB)
26/01/202213:49InvestorsHub NewsWireDefence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9USOTC:DTCFFDefence Therapeutics Inc (QB)
30/11/202117:32InvestorsHub NewsWireDEFENCE THERAPEUTICS VACCINES AND PROGRAM DEVELOPMENTUSOTC:DTCFFDefence Therapeutics Inc (QB)
23/11/202113:24InvestorsHub NewsWireDEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCERUSOTC:DTCFFDefence Therapeutics Inc (QB)
09/11/202116:50InvestorsHub NewsWireDEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORSUSOTC:DTCFFDefence Therapeutics Inc (QB)
03/11/202112:11InvestorsHub NewsWireVACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITSUSOTC:DTCFFDefence Therapeutics Inc (QB)
13/10/202114:15InvestorsHub NewsWireDEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCERUSOTC:DTCFFDefence Therapeutics Inc (QB)
06/10/202114:32InvestorsHub NewsWireDEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMAUSOTC:DTCFFDefence Therapeutics Inc (QB)
29/09/202113:30InvestorsHub NewsWireDEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCERUSOTC:DTCFFDefence Therapeutics Inc (QB)
20/09/202115:01InvestorsHub NewsWireDEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALSUSOTC:DTCFFDefence Therapeutics Inc (QB)
14/09/202113:13InvestorsHub NewsWireDEFENCE THERAPEUTICS SUCCESS IN TESTING IT'S COVID-19 ACCUVAC-PT001 VACCINE IN A NON-RODENT MODELUSOTC:DTCFFDefence Therapeutics Inc (QB)
07/09/202112:35InvestorsHub NewsWireDEFENCE THERAPEUTICS DEVELOPMENT PROGRAM TO ENGINEER A NEW HPV VACCINE INITIATEDUSOTC:DTCFFDefence Therapeutics Inc (QB)
01/09/202115:39InvestorsHub NewsWireThe vaccination specialist is about to become popularUSOTC:DTCFFDefence Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:DTCFF

Your Recent History

BIT
F18786
Vontobel Financial Produ...
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved